Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02541422 · ClinicalTrials.gov registry record · NA
Use of NAC in Alleviation of Hangover Symptoms
A NA study, sponsored by St. Luke's Hospital and Health Network, Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 62
- Enrollment target
NCT02541422 is a NA study that has completed, run by St. Luke's Hospital and Health Network, Pennsylvania. The registered enrollment target is 62 participants.
The verdict
NCT02541422, a NA study, has completed, sponsored by St. Luke's Hospital and Health Network, Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
Study Summary
This will be a double-blinded study involving healthy non-alcoholic (self-reported) volunteers over the age of 21 to consume beer on hospital property in a safe environment to ensure immediate availability to medical attention and to security if needed. Volunteers will be recruited from residency programs, hospital employees, emergency medical personnel, and friends of study investigators. The volunteers will drink to a BAC of 0.1 as checked with a breathalyzer. They will wear a tag around their neck with their study number, which will be hole-punched with every beer consumed, which will be collected at the end of the night for an accurate count of beers consumed per person. They however will not be forced to drink anymore if they are uncomfortable with the amount of alcohol they are consuming and can withdraw from the study at any time. All participants will be required to be driven home by a sober driver once the participant's BAT is 0.02 or less. At the end of the night, the volunteer will be breathalyzed to determine BAC, and given 1 capsule per 3 drinks consumed of either 600 mg N-Acetyl-L-Cysteine or placebo capsules. In the morning, each participate will fill out a Hangover Symptom Score questionnaire, evaluating each hangover symptom on a 0 - 4 point Hangover Symptom Severity scale. A random number generator will be used to determine Placebo or NAC first, then the participant will be given the other treatment at their subsequent encounter. The study will be conducted over the series of many months, and data can be analyzed by self-control comparing the participant's hangover symptom severity as determined by the hangover symptom scale data when using NAC compared to placebo. The data will be analyzed using the numerical values of each category for hangover classification and compare the placebo data to the control data.
Interventions
- OTHER placebo
- DIETARY_SUPPLEMENT N Acetyl Cysteine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2015-08 |
| Est. Completion | 2015-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02541422
The ClinicalTrials.gov registry entry for NCT02541422 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Luke's Hospital and Health Network, Pennsylvania, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT02541422 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02541422 about?
NCT02541422 is a clinical study titled "Use of NAC in Alleviation of Hangover Symptoms". This will be a double-blinded study involving healthy non-alcoholic (self-reported) volunteers over the age of 21 to consume beer on hospital property in a safe environment to ensure immediate availability to medical attention and to security if needed. Volunteers will be recruited from residency pr...
What is the current status of trial NCT02541422?
This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2015-08. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02541422?
The interventions under investigation include: placebo (OTHER), N Acetyl Cysteine (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02541422?
This trial is sponsored by St. Luke's Hospital and Health Network, Pennsylvania, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.